These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 18396857

  • 1. Synthesis and biological activity of fluorinated combretastatin analogues.
    Alloatti D, Giannini G, Cabri W, Lustrati I, Marzi M, Ciacci A, Gallo G, Tinti MO, Marcellini M, Riccioni T, Guglielmi MB, Carminati P, Pisano C.
    J Med Chem; 2008 May 08; 51(9):2708-21. PubMed ID: 18396857
    [Abstract] [Full Text] [Related]

  • 2. Novel combretastatin analogues endowed with antitumor activity.
    Simoni D, Romagnoli R, Baruchello R, Rondanin R, Rizzi M, Pavani MG, Alloatti D, Giannini G, Marcellini M, Riccioni T, Castorina M, Guglielmi MB, Bucci F, Carminati P, Pisano C.
    J Med Chem; 2006 Jun 01; 49(11):3143-52. PubMed ID: 16722633
    [Abstract] [Full Text] [Related]

  • 3. Synthesis and cytotoxic evaluation of combretafurans, potential scaffolds for dual-action antitumoral agents.
    Pirali T, Busacca S, Beltrami L, Imovilli D, Pagliai F, Miglio G, Massarotti A, Verotta L, Tron GC, Sorba G, Genazzani AA.
    J Med Chem; 2006 Aug 24; 49(17):5372-6. PubMed ID: 16913727
    [Abstract] [Full Text] [Related]

  • 4. Combretastatin dinitrogen-substituted stilbene analogues as tubulin-binding and vascular-disrupting agents.
    Siles R, Ackley JF, Hadimani MB, Hall JJ, Mugabe BE, Guddneppanavar R, Monk KA, Chapuis JC, Pettit GR, Chaplin DJ, Edvardsen K, Trawick ML, Garner CM, Pinney KG.
    J Nat Prod; 2008 Mar 24; 71(3):313-20. PubMed ID: 18303849
    [Abstract] [Full Text] [Related]

  • 5. Further naphthylcombretastatins. An investigation on the role of the naphthalene moiety.
    Maya AB, Pérez-Melero C, Mateo C, Alonso D, Fernández JL, Gajate C, Mollinedo F, Peláez R, Caballero E, Medarde M.
    J Med Chem; 2005 Jan 27; 48(2):556-68. PubMed ID: 15658869
    [Abstract] [Full Text] [Related]

  • 6. Antineoplastic agents. 445. Synthesis and evaluation of structural modifications of (Z)- and (E)-combretastatin A-41.
    Pettit GR, Rhodes MR, Herald DL, Hamel E, Schmidt JM, Pettit RK.
    J Med Chem; 2005 Jun 16; 48(12):4087-99. PubMed ID: 15943482
    [Abstract] [Full Text] [Related]

  • 7. Design, synthesis, biochemical, and biological evaluation of nitrogen-containing trifluoro structural modifications of combretastatin A-4.
    Hall JJ, Sriram M, Strecker TE, Tidmore JK, Jelinek CJ, Kumar GD, Hadimani MB, Pettit GR, Chaplin DJ, Trawick ML, Pinney KG.
    Bioorg Med Chem Lett; 2008 Sep 15; 18(18):5146-9. PubMed ID: 18710804
    [Abstract] [Full Text] [Related]

  • 8. Synthesis, anticancer activity, and inhibition of tubulin polymerization by conformationally restricted analogues of lavendustin A.
    Mu F, Hamel E, Lee DJ, Pryor DE, Cushman M.
    J Med Chem; 2003 Apr 24; 46(9):1670-82. PubMed ID: 12699385
    [Abstract] [Full Text] [Related]

  • 9. 1,5-Disubstituted 1,2,3-triazoles as cis-restricted analogues of combretastatin A-4: Synthesis, molecular modeling and evaluation as cytotoxic agents and inhibitors of tubulin.
    Odlo K, Hentzen J, dit Chabert JF, Ducki S, Gani OA, Sylte I, Skrede M, Flørenes VA, Hansen TV.
    Bioorg Med Chem; 2008 May 01; 16(9):4829-38. PubMed ID: 18396050
    [Abstract] [Full Text] [Related]

  • 10. Synthesis and antimicrotubule activity of combretatropone derivatives.
    Janik ME, Bane SL.
    Bioorg Med Chem; 2002 Jun 01; 10(6):1895-903. PubMed ID: 11937347
    [Abstract] [Full Text] [Related]

  • 11. Synthesis and biological evaluation of cis-restricted triazole/tetrazole mimics of combretastatin-benzothiazole hybrids as tubulin polymerization inhibitors and apoptosis inducers.
    Subba Rao AV, Swapna K, Shaik SP, Lakshma Nayak V, Srinivasa Reddy T, Sunkari S, Shaik TB, Bagul C, Kamal A.
    Bioorg Med Chem; 2017 Feb 01; 25(3):977-999. PubMed ID: 28034647
    [Abstract] [Full Text] [Related]

  • 12. A fluorine scan of a tubulin polymerization inhibitor isocombretastatin A-4: Design, synthesis, molecular modelling, and biological evaluation.
    Naret T, Bignon J, Bernadat G, Benchekroun M, Levaique H, Lenoir C, Dubois J, Pruvost A, Saller F, Borgel D, Manoury B, Leblais V, Darrigrand R, Apcher S, Brion JD, Schmitt E, Leroux FR, Alami M, Hamze A.
    Eur J Med Chem; 2018 Jan 01; 143():473-490. PubMed ID: 29202409
    [Abstract] [Full Text] [Related]

  • 13. Synthesis, antiproliferative, anti-tubulin activity, and docking study of new 1,2,4-triazoles as potential combretastatin analogues.
    Mustafa M, Abdelhamid D, Abdelhafez EMN, Ibrahim MAA, Gamal-Eldeen AM, Aly OM.
    Eur J Med Chem; 2017 Dec 01; 141():293-305. PubMed ID: 29031074
    [Abstract] [Full Text] [Related]

  • 14. Design, synthesis, and biological evaluation of combretastatin nitrogen-containing derivatives as inhibitors of tubulin assembly and vascular disrupting agents.
    Monk KA, Siles R, Hadimani MB, Mugabe BE, Ackley JF, Studerus SW, Edvardsen K, Trawick ML, Garner CM, Rhodes MR, Pettit GR, Pinney KG.
    Bioorg Med Chem; 2006 May 01; 14(9):3231-44. PubMed ID: 16442292
    [Abstract] [Full Text] [Related]

  • 15. Antineoplastic agents. 579. Synthesis and cancer cell growth evaluation of E-stilstatin 3: a resveratrol structural modification.
    Pettit GR, Melody N, Thornhill A, Knight JC, Groy TL, Herald CL.
    J Nat Prod; 2009 Sep 01; 72(9):1637-42. PubMed ID: 19719153
    [Abstract] [Full Text] [Related]

  • 16. Synthesis and evaluation of double bond substituted combretastatins.
    Hadfield JA, Gaukroger K, Hirst N, Weston AP, Lawrence NJ, McGown AT.
    Eur J Med Chem; 2005 Jun 01; 40(6):529-41. PubMed ID: 15922837
    [Abstract] [Full Text] [Related]

  • 17. Synthesis and biological activity of mustard derivatives of combretastatins.
    Coggiola B, Pagliai F, Allegrone G, Genazzani AA, Tron GC.
    Bioorg Med Chem Lett; 2005 Aug 01; 15(15):3551-4. PubMed ID: 15963722
    [Abstract] [Full Text] [Related]

  • 18. Antineoplastic agents. 410. Asymmetric hydroxylation of trans-combretastatin A-4.
    Pettit GR, Toki BE, Herald DL, Boyd MR, Hamel E, Pettit RK, Chapuis JC.
    J Med Chem; 1999 Apr 22; 42(8):1459-65. PubMed ID: 10212132
    [Abstract] [Full Text] [Related]

  • 19. Synthesis and biological evaluation of carbamates derived from aminocombretastatin A-4 as vascular disrupting agents.
    Conesa-Milián L, Falomir E, Murga J, Carda M, Meyen E, Liekens S, Alberto Marco J.
    Eur J Med Chem; 2018 Mar 10; 147():183-193. PubMed ID: 29432949
    [Abstract] [Full Text] [Related]

  • 20. Design, synthesis and biological evaluation of novel vicinal diaryl-substituted 1H-Pyrazole analogues of combretastatin A-4 as highly potent tubulin polymerization inhibitors.
    Romagnoli R, Oliva P, Salvador MK, Camacho ME, Padroni C, Brancale A, Ferla S, Hamel E, Ronca R, Grillo E, Bortolozzi R, Rruga F, Mariotto E, Viola G.
    Eur J Med Chem; 2019 Nov 01; 181():111577. PubMed ID: 31400707
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.